Company No:
Contents
DIRECTORS | J Kirkbride |
B Lampl |
REGISTERED OFFICE | The Health And Wellbeing Innovation Centre |
Treliske | |
Truro | |
TR1 3FF | |
United Kingdom |
COMPANY NUMBER | 13427910 (England and Wales) |
CHARTERED ACCOUNTANTS | Francis Clark LLP |
Lowin House | |
Tregolls Road | |
Truro | |
Cornwall TR1 2NA |
Note | 2022 | 2021 | ||
£ | £ | |||
Fixed assets | ||||
Tangible assets | 3 |
|
|
|
13,041 | 0 | |||
Current assets | ||||
Stocks |
|
|
||
Debtors | 4 |
|
|
|
Cash at bank and in hand |
|
|
||
107,981 | 3,069 | |||
Creditors: amounts falling due within one year | 5 | (
|
(
|
|
Net current assets/(liabilities) | 58,149 | (59,209) | ||
Total assets less current liabilities | 71,190 | (59,209) | ||
Provision for liabilities | (
|
|
||
Net assets/(liabilities) |
|
(
|
||
Capital and reserves | ||||
Called-up share capital |
|
|
||
Profit and loss account |
|
(
|
||
Total shareholders' funds/(deficit) |
|
(
|
Directors' responsibilities:
The financial statements of Hypneuma Limited (registered number:
B Lampl
Director |
The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.
Hypneuma Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is The Health And Wellbeing Innovation Centre, Treliske, Truro, TR1 3FF, United Kingdom.
The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.
The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.
The directors have assessed the Balance Sheet and likely future cash flows at the date of approving these financial statements. The directors have a reasonable expectation that the Company has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.
Turnover from the sale of goods is recognised when the goods are physically delivered to the customer.
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Balance Sheet date.
Deferred tax
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the Company's financial statements. Deferred tax is provided in full on timing differences which result in an obligation to pay more or less tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on tax rates and laws substantively enacted at the balance sheet date. Deferred tax assets and liabilities are not discounted.
Plant and machinery |
|
Fixtures and fittings |
|
Assets, other than those measured at fair value, are assessed for indicators of impairment at each Balance Sheet date. If there is objective evidence of impairment, an impairment loss is recognised in the Statement of Income and Retained Earnings as described below.
Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.
Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.
2022 | 2021 | ||
Number | Number | ||
Monthly average number of persons employed by the Company during the year, including directors |
|
|
Plant and machinery | Fixtures and fittings | Total | |||
£ | £ | £ | |||
Cost | |||||
At 01 January 2022 |
|
|
|
||
Additions |
|
|
|
||
At 31 December 2022 |
|
|
|
||
Accumulated depreciation | |||||
At 01 January 2022 |
|
|
|
||
Charge for the financial year |
|
|
|
||
At 31 December 2022 |
|
|
|
||
Net book value | |||||
At 31 December 2022 |
|
|
|
||
At 31 December 2021 |
|
|
|
2022 | 2021 | ||
£ | £ | ||
Trade debtors |
|
|
|
Other debtors |
|
|
|
|
|
2022 | 2021 | ||
£ | £ | ||
Trade creditors |
|
|
|
Taxation and social security |
|
|
|
Other creditors |
|
|
|
|
|
Commitments
Total future minimum lease payments under non-cancellable operating leases are as follows:
2022 | 2021 | ||
£ | £ | ||
within one year |
|
|
The commitment relates to the rental of the property from which the company operates. There is no commitment at 31 December 2022.
Other related party transactions
2022 | 2021 | ||
£ | £ | ||
Global Inhalation Equipment Limited | 0 | 57,093 | |
General Anesthetic Services Inc | 0 | 2,501 |
During the year amounts due to Global Inhalation Equipment Limited of £187,985 and amounts due to General Anesthetic Services Inc of £125,096 were written off. These amounts have been included within other operating income.